ATAI
vs
S&P 500
ATAI
S&P 500
Over the past 12 months, ATAI has significantly outperformed S&P 500, delivering a return of +173% compared to the S&P 500's +29% growth.
Stocks Performance
ATAI vs S&P 500
Performance Gap
ATAI vs S&P 500
Performance By Year
ATAI vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ATAI Life Sciences NV
Glance View
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.